{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:32:27Z","timestamp":1792211547433,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T00:00:00Z","timestamp":1457740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T00:00:00Z","timestamp":1457740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["K24-EY019098"],"award-info":[{"award-number":["K24-EY019098"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00417-016-3312-3","type":"journal-article","created":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T02:22:46Z","timestamp":1457749366000},"page":"923-928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease"],"prefix":"10.1007","volume":"254","author":[{"given":"Ujwala S.","family":"Saboo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Amparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasanain","family":"Shikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,12]]},"reference":[{"key":"3312_CR1","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/jama.2010.491","volume":"303","author":"A Gratwohl","year":"2010","unstructured":"Gratwohl A, Baldomero H, Aljurf M et al (2010) Hematopoietic stem cell transplantation: a global perspective. JAMA 303:1617\u20131624","journal-title":"JAMA"},{"key":"3312_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.me.35.020184.000245","volume":"35","author":"ED Thomas","year":"1984","unstructured":"Thomas ED, Clift RA, Storb R (1984) Indications for marrow transplantation. Annu Rev Med 35:1\u20139","journal-title":"Annu Rev Med"},{"key":"3312_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1532\/IJH97.04015","volume":"79","author":"E Kansu","year":"2004","unstructured":"Kansu E (2004) The pathophysiology of chronic graft-versus-host disease. Int J Hematol 79:209\u2013215","journal-title":"Int J Hematol"},{"key":"3312_CR4","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/bmt.2010.5","volume":"45","author":"S Pallua","year":"2010","unstructured":"Pallua S, Giesinger J, Oberguggenberger A et al (2010) Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplant 45:1534\u20131539","journal-title":"Bone Marrow Transplant"},{"key":"3312_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.survophthal.2012.08.004","volume":"58","author":"H Shikari","year":"2013","unstructured":"Shikari H, Antin JH, Dana R (2013) Ocular graft-versus-host disease: a review. Surv Ophthalmol 58:233\u2013251","journal-title":"Surv Ophthalmol"},{"key":"3312_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/ACI.0b013e328357b4b9","volume":"12","author":"M Hessen","year":"2012","unstructured":"Hessen M, Akpek EK (2012) Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 12:540\u2013547","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"3312_CR7","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00417-013-2301-z","volume":"251","author":"EM Espana","year":"2013","unstructured":"Espana EM, Shah S, Santhiago MR, Singh AD (2013) Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol 251:1257\u20131266","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3312_CR8","doi-asserted-by":"publisher","first-page":"S19-2","DOI":"10.1097\/00003226-200310001-00004","volume":"22","author":"Y Ogawa","year":"2003","unstructured":"Ogawa Y, Kuwana M (2003) Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 22:S19-2","journal-title":"Cornea"},{"key":"3312_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/01.icu.0000233952.09595.d8","volume":"17","author":"SK Kim","year":"2006","unstructured":"Kim SK (2006) Update on ocular graft versus host disease. Curr Opin Ophthalmol 17:344\u2013348","journal-title":"Curr Opin Ophthalmol"},{"key":"3312_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/01.ico.0000220776.93852.d9","volume":"25","author":"JH Tsai","year":"2006","unstructured":"Tsai JH, Derby E, Holland EJ, Khatana AK (2006) Incidence and prevalence of glaucoma in severe ocular surface disease. Cornea 25:530\u2013532","journal-title":"Cornea"},{"key":"3312_CR11","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2147\/OPTH.S32936","volume":"6","author":"M Ang","year":"2012","unstructured":"Ang M, Ti SE, Loh R et al (2012) Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis. Clin Ophthalmol 6:1253\u20131258","journal-title":"Clin Ophthalmol"},{"key":"3312_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0161-6420(89)32942-3","volume":"96","author":"J Tauber","year":"1989","unstructured":"Tauber J, Melamed S, Foster CS (1989) Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology 96:33\u201337","journal-title":"Ophthalmology"},{"key":"3312_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10384-008-0605-z","volume":"53","author":"K Yuki","year":"2009","unstructured":"Yuki K, Shimmura S, Shiba D, Tsubota K (2009) End-stage glaucoma in Stevens\u2013Johnson syndrome. Jpn J Ophthalmol 53:68\u201370","journal-title":"Jpn J Ophthalmol"},{"key":"3312_CR14","first-page":"163","volume":"17","author":"R Jones 3rd","year":"2006","unstructured":"Jones R 3rd, Rhee DJ (2006) Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol 17:163\u2013167","journal-title":"Curr Opin Ophthalmol"},{"key":"3312_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/IJG.0b013e318264cd68","volume":"23","author":"R Batra","year":"2014","unstructured":"Batra R, Tailor R, Mohamed S (2014) Ocular surface disease exacerbated glaucoma: optimizing the ocular surface improves intraocular pressure control. J Glaucoma 23:56\u201360","journal-title":"J Glaucoma"},{"key":"3312_CR16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/ICO.0000000000000340","volume":"34","author":"H Shikari","year":"2015","unstructured":"Shikari H, Amparo F, Saboo U, Dana R (2015) Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation. Cornea 34:243\u2013247","journal-title":"Cornea"},{"key":"3312_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ et al (2002) The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701\u2013713","journal-title":"Arch Ophthalmol"},{"key":"3312_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1185\/03007995.2012.681036","volume":"28","author":"LJ Katz","year":"2012","unstructured":"Katz LJ, Rauchman SH, Cottingham AJ Jr et al (2012) Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study. Curr Med Res Opin 28:781\u2013788","journal-title":"Curr Med Res Opin"},{"key":"3312_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3928\/23258160-20130909-07","volume":"44","author":"S Pershing","year":"2013","unstructured":"Pershing S, Bakri SJ, Moshfeghi DM (2013) Ocular hypertension and intraocular pressure asymmetry after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina 44:460\u2013464","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"3312_CR20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.ajo.2006.01.019","volume":"141","author":"SM Kymes","year":"2006","unstructured":"Kymes SM, Kass MA, Anderson DR et al (2006) Ocular Hypertension Treatment Study Group (OHTS). Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study. Am J Ophthalmol 141:997\u20131008","journal-title":"Am J Ophthalmol"},{"key":"3312_CR21","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/S0161-6420(96)30449-1","volume":"103","author":"P Mitchell","year":"1996","unstructured":"Mitchell P, Smith W, Attebo K, Healey PR (1996) Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 103:1661\u20131669","journal-title":"Ophthalmology"},{"key":"3312_CR22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1136\/bjo.2003.028548","volume":"88","author":"JG Crowston","year":"2004","unstructured":"Crowston JG, Hopley CR, Healey PR (2004) The effect of optic disc diameter on vertical cup to disc ratio percentiles in a population-based cohort: the Blue Mountains Eye Study. Br J Ophthalmol 88:766\u2013770","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"3312_CR23","first-page":"137","volume":"2","author":"AA Ayansiji","year":"2008","unstructured":"Ayansiji AA, Olasunkanmi OF, Olarongbe MA et al (2008) Clinical findings among Nigerian paediatric glaucoma suspects during a school eye health survey. Open Ophthalmol J 2(2):137\u2013140","journal-title":"Open Ophthalmol J"},{"key":"3312_CR24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/archopht.1994.01090180121046","volume":"112","author":"MC Leske","year":"1994","unstructured":"Leske MC, Connell AM, Schachat AP et al (1994) The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 112:821\u2013829","journal-title":"Arch Ophthalmol"},{"key":"3312_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.survophthal.2006.12.008","volume":"52","author":"P Brusini","year":"2007","unstructured":"Brusini P, Johnson CA (2007) Staging functional damage in glaucoma: review of different classification methods. Surv Ophthalmol 52:156\u2013179","journal-title":"Surv Ophthalmol"},{"key":"3312_CR26","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.1167\/iovs.15-16721","volume":"56","author":"P Sriram","year":"2015","unstructured":"Sriram P, Klistorner A, Graham S et al (2015) Optimizing the detection of preperimetric glaucoma by combining structural and functional tests. Invest Ophthalmol Vis Sci 56:7794\u20137800","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3312_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0039-6257(80)90015-6","volume":"24","author":"HM Leibowitz","year":"1980","unstructured":"Leibowitz HM, Krueger DE, Maunder LR et al (1980) The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973\u20131975. Surv Ophthalmol 24:335\u2013610","journal-title":"Surv Ophthalmol"},{"key":"3312_CR28","first-page":"2224","volume":"33","author":"BE Klein","year":"1992","unstructured":"Klein BE, Klein R, Linton KL (1992) Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 33:2224\u20132228","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3312_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/jama.1991.03470030069026","volume":"266","author":"JM Tielsch","year":"1991","unstructured":"Tielsch JM, Sommer A, Katz J et al (1991) Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 266:369\u2013374","journal-title":"JAMA"},{"key":"3312_CR30","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.ophtha.2004.01.025","volume":"111","author":"R Varma","year":"2004","unstructured":"Varma R, Ying-Lai M, Francis BA et al (2004) Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 111:1439\u201348","journal-title":"Ophthalmology"},{"key":"3312_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/bjo.77.1.17","volume":"77","author":"M Coffey","year":"1993","unstructured":"Coffey M, Reidy A, Wormald R et al (1993) Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol 77:17\u201321","journal-title":"Br J Ophthalmol"},{"key":"3312_CR32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1136\/bjo.50.10.570","volume":"50","author":"FC Hollows","year":"1996","unstructured":"Hollows FC, Graham PA (1996) Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. Br J Ophthalmol 50:570\u2013586","journal-title":"Br J Ophthalmol"},{"key":"3312_CR33","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/archopht.1994.01090180121046","volume":"112","author":"MC Leske","year":"1994","unstructured":"Leske MC, Connell AM, Schachat AP, Hyman L (1994) The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 112:821\u2013829","journal-title":"Arch Ophthalmol"},{"key":"3312_CR34","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1021\/js9802594","volume":"87","author":"MR Prausnitz","year":"1998","unstructured":"Prausnitz MR, Noonan JS (1998) Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci 87:1479\u20131488","journal-title":"J Pharm Sci"},{"key":"3312_CR35","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/03639040701377995","volume":"33","author":"S Yasueda","year":"2007","unstructured":"Yasueda S, Higashiyama M, Yamaguchi M et al (2007) Corneal critical barrier against the penetration of dexamethasone and lomefloxacin hydrochloride: evaluation by the activation energy for drug partition and diffusion in cornea. Drug Dev Ind Pharm 33:805\u2013811","journal-title":"Drug Dev Ind Pharm"},{"key":"3312_CR36","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.ophtha.2009.04.054","volume":"116","author":"KF Tabbara","year":"2009","unstructured":"Tabbara KF, Al-Ghamdi A, Al-Mohareb F et al (2009) Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology 116:1624\u20131629","journal-title":"Ophthalmology"},{"key":"3312_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000328630","volume":"47","author":"MR Razeghinejad","year":"2012","unstructured":"Razeghinejad MR, Katz LJ (2012) Steroid-induced iatrogenic glaucoma. Ophthalmic Res 47:66\u201380","journal-title":"Ophthalmic Res"},{"key":"3312_CR38","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(97)03392-8","volume":"350","author":"E Garbe","year":"1997","unstructured":"Garbe E, LeLorier J, Boivin JF et al (1997) Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet 350:979\u2013982","journal-title":"Lancet"},{"key":"3312_CR39","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10067-013-2214-6","volume":"32","author":"L Carli","year":"2013","unstructured":"Carli L, Tani C, Querci F et al (2013) Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists\u2019 practice for the monitoring of glucocorticoid eye toxicity. Clin Rheumatol 32:1071\u20131073","journal-title":"Clin Rheumatol"},{"key":"3312_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0002-9394(63)91858-0","volume":"56","author":"J Alfano","year":"1963","unstructured":"Alfano J (1963) Changes in the intraocular pressure associated with systemic steroid therapy. Am J Ophthalmol 56:245\u2013247","journal-title":"Am J Ophthalmol"},{"key":"3312_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/bjo.66.5.290","volume":"66","author":"HP Adhikary","year":"1982","unstructured":"Adhikary HP, Sells RA, Basu PK (1982) Ocular complications of systemic steroid after renal transplantation and their association with HLA. Br J Ophthalmol 66:290\u2013291","journal-title":"Br J Ophthalmol"},{"key":"3312_CR42","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/ICO.0b013e3181a3c52f","volume":"10","author":"EJ Holland","year":"2009","unstructured":"Holland EJ, Djalilian AR, Sanderson JP (2009) Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation. Cornea 10:1139\u20131143","journal-title":"Cornea"},{"key":"3312_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","volume":"21","author":"S Arai","year":"2015","unstructured":"Arai S, Arora M, Wang T et al (2015) Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 21:266\u2013274","journal-title":"Biol Blood Marrow Transplant"},{"key":"3312_CR44","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","volume":"373","author":"JL Ferrara","year":"2009","unstructured":"Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373:1550\u20131561","journal-title":"Lancet"},{"key":"3312_CR45","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","volume":"29","author":"RD Fechtner","year":"2010","unstructured":"Fechtner RD, Godfrey DG, Budenz D et al (2010) Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 29:618\u2013621","journal-title":"Cornea"},{"key":"3312_CR46","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.ophtha.2013.03.045","volume":"120","author":"PM Mathews","year":"2013","unstructured":"Mathews PM, Ramulu PY, Friedman DS et al (2013) Evaluation of ocular surface disease in patients with glaucoma. Ophthalmology 120:2241\u20132248","journal-title":"Ophthalmology"},{"key":"3312_CR47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/112067210701700311","volume":"17","author":"N Jaenen","year":"2007","unstructured":"Jaenen N, Baudouin C, Pouliquen P et al (2007) Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 17:341\u2013349","journal-title":"Eur J Ophthalmol"},{"key":"3312_CR48","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/bjo.86.4.418","volume":"86","author":"PJ Pisella","year":"2002","unstructured":"Pisella PJ, Pouliquen P, Baudouin C (2002) Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 86:418\u2013423","journal-title":"Br J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3312-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-016-3312-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3312-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3312-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T13:08:04Z","timestamp":1589634484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-016-3312-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,12]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["3312"],"URL":"https:\/\/doi.org\/10.1007\/s00417-016-3312-3","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,12]]},"assertion":[{"value":"17 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"National Eye Institute, National Institutes of Health provided financial support in the form of National Institutes of Health (Grant: K24-EY019098) funding. This work was also supported by funding from Research to Prevent Blindness. The sponsor had no role in the design or conduct of this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This work was supported by the National Eye Institute, National Institutes of Health (Grant: K24-EY019098) and Research to Prevent Blindness. The funding organizations had no role in the design or conduct of this research.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial support"}}]}}